Cargando…
特异性抗体免疫组化法检测EGFR突变价值的meta分析
BACKGROUND AND OBJECTIVE: It has been proven that epidermal growth factor receptor (EGFR) mutation is the most important predictive factor for determining the effect of EGFR tyrosine kinase inhibitors (TKIs) applied to non-small cell lung cancer (NSCLC) patients. The patients with EGFR mutations res...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000101/ https://www.ncbi.nlm.nih.gov/pubmed/24949684 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.06.03 |